Miaoling He

596 total citations
20 papers, 384 citations indexed

About

Miaoling He is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Miaoling He has authored 20 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Miaoling He's work include Prostate Cancer Treatment and Research (7 papers), Hormonal and reproductive studies (6 papers) and Metal complexes synthesis and properties (4 papers). Miaoling He is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Hormonal and reproductive studies (6 papers) and Metal complexes synthesis and properties (4 papers). Miaoling He collaborates with scholars based in United States and China. Miaoling He's co-authors include Jeremy O. Jones, Sumanta K. Pal, Maya Otto‐Duessel, Boyang Yu, Marcin Kortylewski, Jiangwei Tian, Xiaonan Ma, Xie‐an Yu, Przemyslaw Twardowski and Junping Kou and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Chemistry and Cancer.

In The Last Decade

Miaoling He

19 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miaoling He United States 11 176 157 127 99 56 20 384
Natalia V. Potoldykova Russia 13 113 0.6× 164 1.0× 75 0.6× 28 0.3× 37 0.7× 34 363
Hanning Li China 15 85 0.5× 210 1.3× 105 0.8× 69 0.7× 9 0.2× 31 397
Ziping Wu China 11 120 0.7× 182 1.2× 196 1.5× 103 1.0× 14 0.3× 19 383
Milan Král Czechia 13 168 1.0× 218 1.4× 90 0.7× 132 1.3× 17 0.3× 41 444
Johan Swinnen Belgium 7 99 0.6× 131 0.8× 107 0.8× 47 0.5× 33 0.6× 16 330
Sayeda Yasmin‐Karim United States 14 101 0.6× 173 1.1× 91 0.7× 163 1.6× 129 2.3× 32 563
Л. В. Спирина Russia 12 68 0.4× 238 1.5× 121 1.0× 81 0.8× 20 0.4× 95 430
Sylvain L’Espérance Canada 12 40 0.2× 261 1.7× 111 0.9× 157 1.6× 23 0.4× 15 530
José Luís Hernández Spain 11 58 0.3× 239 1.5× 64 0.5× 71 0.7× 28 0.5× 22 356

Countries citing papers authored by Miaoling He

Since Specialization
Citations

This map shows the geographic impact of Miaoling He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miaoling He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miaoling He more than expected).

Fields of papers citing papers by Miaoling He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miaoling He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miaoling He. The network helps show where Miaoling He may publish in the future.

Co-authorship network of co-authors of Miaoling He

This figure shows the co-authorship network connecting the top 25 collaborators of Miaoling He. A scholar is included among the top collaborators of Miaoling He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miaoling He. Miaoling He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomenius, Michael J., Jason K. Kirby, Roman V. Agafonov, et al.. (2023). CFT7455, a novel IKZF1/3 degrader, demonstrates potent activity in peripheral and CNS models of NHL as a single agent or in combination with clinically approved agents. Hematological Oncology. 41(S2). 550–551. 4 indexed citations
2.
Pal, Sumanta K., Ben Yi Tew, Miaoling He, et al.. (2019). Mechanistic Investigation of the Androgen Receptor DNA-Binding Domain Inhibitor Pyrvinium. ACS Omega. 4(2). 2472–2481. 19 indexed citations
3.
Yu, Xie‐an, Miaoling He, Xiaonan Ma, et al.. (2019). Targeted Myocardial Hypoxia Imaging Using a Nitroreductase-Activatable Near-Infrared Fluorescent Nanoprobe. Analytical Chemistry. 91(10). 6585–6592. 59 indexed citations
4.
5.
Pal, Sumanta K., Miaoling He, Lin Chen, et al.. (2017). Synaptophysin expression on circulating tumor cells in patients with castration resistant prostate cancer undergoing treatment with abiraterone acetate or enzalutamide. Urologic Oncology Seminars and Original Investigations. 36(4). 162.e1–162.e6. 20 indexed citations
6.
Tew, Ben Yi, Teresa Hong, Maya Otto‐Duessel, et al.. (2017). Vitamin K epoxide reductase regulation of androgen receptor activity. Oncotarget. 8(8). 13818–13831. 23 indexed citations
7.
Pal, Sumanta K., Jaymala Patel, Miaoling He, et al.. (2017). Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration‐resistant prostate cancer (CRPC). Cancer. 124(6). 1216–1224. 51 indexed citations
8.
Tew, Ben Yi, Sumanta K. Pal, Miaoling He, et al.. (2016). Vitamin K epoxide reductase expression and prostate cancer risk. Urologic Oncology Seminars and Original Investigations. 35(3). 112.e13–112.e18. 6 indexed citations
9.
Zhou, Ye, Maya Otto‐Duessel, Miaoling He, et al.. (2016). Low Testosterone Alters the Activity of Mouse Prostate Stem Cells. The Prostate. 77(5). 530–541. 2 indexed citations
10.
Pal, Sumanta K., Miaoling He, Tommy R. Tong, et al.. (2014). RNA-seq Reveals Aurora Kinase–Driven mTOR Pathway Activation in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma. Molecular Cancer Research. 13(1). 130–137. 37 indexed citations
11.
Pal, Sumanta K., Miaoling He, Timothy G. Wilson, et al.. (2014). Detection and Phenotyping of Circulating Tumor Cells in High-Risk Localized Prostate Cancer. Clinical Genitourinary Cancer. 13(2). 130–136. 46 indexed citations
12.
Otto‐Duessel, Maya, Miaoling He, Leila Su, et al.. (2013). Ligand-Independent and Tissue-Selective Androgen Receptor Inhibition by Pyrvinium. ACS Chemical Biology. 9(3). 692–702. 46 indexed citations
13.
Zhou, Ye, Maya Otto‐Duessel, Miaoling He, et al.. (2013). Low systemic testosterone levels induce androgen maintenance in benign rat prostate tissue. Journal of Molecular Endocrinology. 51(1). 143–153. 18 indexed citations
14.
Pan, Chong-xian, Miaoling He, Tao Li, et al.. (2013). Abstract 1183: Phase 0 microdosing trial quantitating DNA adduct formation to identify platinum chemosensitivity: from bench to bedside.. Cancer Research. 73(8_Supplement). 1183–1183. 1 indexed citations
15.
Otto‐Duessel, Maya, Miaoling He, & Jeremy O. Jones. (2012). Tissue-Selective Regulation of Androgen-Responsive Genes. Endocrine Research. 37(4). 203–215. 14 indexed citations
16.
Otto‐Duessel, Maya, et al.. (2012). Enhanced evaluation of selective androgen receptor modulators in vivo. Andrology. 1(1). 29–36. 5 indexed citations
17.
Pal, Sumanta K., Clayton Lau, Miaoling He, et al.. (2012). Detecting circulating tumor cells (CTCs) in patients with high-risk, localized prostate cancer using the CellSearch platform.. Journal of Clinical Oncology. 30(15_suppl). e15178–e15178. 1 indexed citations
18.
Pan, Chong-xian, Miaoling He, Ralph de Vere White, et al.. (2011). A phase 0 microdosing trial to identify chemoresistance in bladder cancer.. Journal of Clinical Oncology. 29(7_suppl). 264–264. 1 indexed citations
19.
Henderson, Paul T., Tao Li, Miaoling He, et al.. (2010). A microdosing approach for characterizing formation and repair of carboplatin–DNA monoadducts and chemoresistance. International Journal of Cancer. 129(6). 1425–1434. 30 indexed citations
20.
He, Miaoling, Ralph de Vere White, David R. Gandara, et al.. (2009). Design of a phase 0 microdosing trial for correlation of platinum-induced DNA damage to chemotherapy outcomes. Journal of Clinical Oncology. 27(15_suppl). 2543–2543. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalia V. Potoldykova Breakdown of academic impact, for papers by Hanning Li Breakdown of academic impact, for papers by Ziping Wu Breakdown of academic impact, for papers by Milan Král Breakdown of academic impact, for papers by Johan Swinnen Breakdown of academic impact, for papers by Sayeda Yasmin‐Karim Breakdown of academic impact, for papers by Л. В. Спирина Breakdown of academic impact, for papers by Sylvain L’Espérance Breakdown of academic impact, for papers by José Luís Hernández
Rankless by CCL
2026